Laila Nutraceuticals

Laila Impex

Kasina Laila Innova Pharmaceuticals Private Limited

M/s Laila Nutraceuticals

Krishanu Sengupta

Rama Raju Gokaraju

Ganga Raju Gokaraju

Kiran Bhupathiraju

Trimurtulu Golakoti

Venkata Kanaka Ranga Raju Gokaraju

Venkata Krishna Raju Alluri

Trimurtulu Golakati

Sudhakar Kasina

Venkateswarlu Somepalli

Venkata Subbaraju Gottumukkala

Sivaramakrishna Chillara

Kiran Bhuphatiraju

Venketa Kanaka Ranga Raju Gokaraju

Kiran Bhupatiraju

Golakoti Trimurtulu

Venkata Kanaka Gokaraju

Venkata Krishna Alluri

A method for treating an inflammation, arthritis, or a joint disease in a patient in need thereof, comprising administering to the patient an herbal composition, where the herbal composition includes a therapeutically effective amount of an extract of; a therapeutically effective amount of an extract of; and a therapeutically effective amount of a non-acidic, water-immiscible organic solvent extract of aresin.

Synergistic dietary supplement compositions for the prevention, treatment or control of inflammatory disorders

The invention discloses novel dietary supplements or herbal product comprising at least one ingredient selected from the extracts or fractions derived fromfruit,stem bark,tender stem andfruit or their compositions in combination with at least one compound selected from biological actives, herbal extracts, minerals, amino acids, proteins, vitamins, excipient, diluent or carrier as a natural energy enhancer to provide an onset and steady maintenance of energy and for improving muscle strength, muscle mass and mental alertness, for treating sarcopenia and muscular atrophy in a warm blooded animal or mammal in need thereof.

Dietary supplements and compositions for enhancing physical performance and energy levels

An herbal composition, comprising a therapeutically effective amount of an extract ofa therapeutically effective amount of an extract ofand a therapeutically effective amount of a non-acidic, water-immiscible organic solvent extract of aresin.

The present invention discloses novel synergistic dietary supplement compositions comprising at least two ingredients selected from the extracts and fractions derived fromandas natural energy enhancer for enhancing physical performance, muscle strength, muscle mass, mental alertness and energy levels in a mammal.

Synergistic dietary supplement compositions for enhancing physical performance and energy levels

Pharmaceutical/dietary supplements and food ingredient(s) derived fromare used for controlling or treating a metabolic disorder. The supplements and food ingredient(s) are selected fromextract(s), fraction(s), active compound(s) and phytochemical(s) or mixtures thereof and their compositions, preferably in combination with at least one component selected from the extract(s), fraction(s), active compound(s) and phytochemical(s) or mixtures thereof derived from. The ingredients and the composition(s) can be used for the control, prevention and treatment of obesity, metabolic syndrome, diabetes and other metabolic disorders, and also to regulate energy expenditure, prevention of atherosclerotic plaques in coronary artery and abdominal aorta, increase insulin sensitivity, improve glucose tolerance, lower triglyceride levels and balance glucose levels in mammals.

Composition from Sphaeranthus indicus and Garcinia mangostana for the control of metabolic syndrome

The present invention discloses the extracts ofor the purified fractions isolated there from and the dietary, nutraceutical and pharmaceutical compositions comprising the same or optionally in combination with one or more known anti-obesic agents useful for the purpose of inhibition, amelioration or prevention of adipogenesis and lipolysis involved diseases. The invention further discloses a method for treating or preventing obesity and adipogenesis and lipolysis involved diseases using the compositions containing the extracts of purified fractions of

Anti-obese compositions containing holoptelea integrifolia extracts

The current disclosure discloses acetogenin(s), extract(s)/fraction(s) standardized to acetogenin(s) comprising terminal &#x3b1;,&#x3b2;-unsaturated-&#x3b3;-methyl-&#x3b3;-lactone moiety derived fromor their compositions for prevention, treatment, inhibition or controlling inflammation and immune related diseases or disorders mediated through cytokines/chemokines or other biomarkers. The disclosure further discloses saidderived acetogenin(s), extract(s)/fraction(s) or their compositions for prevention, treatment, inhibition or controlling metabolic diseases/disorders.

Extracts, fractions and compositions comprising acetogenins and their applications

Herbal compositions are useful for inhibition, amelioration or prevention of adipogenesis mediated diseases such as obesity, lipid storage disease and hyperlipemia. The herbal compositions comprise biologically effective amounts of extracts or fractions fromin combination with one or more of the extracts or fractions derived fromandas active ingredients. The compositions optionally contain a bio-enhancing agent or a bio-protecting agent, along with biologically acceptable carriers or diluents. The herbal compositions may be used in a method for treating or preventing adipogenesis involved diseases in mammals.

[object Object]

The invention relates pharmaceutical/dietary supplement/food ingredient(s) selected from the extract(s), fraction(s), active compound(s) and phytochemical(s) or mixtures thereof derived fromand their compositions, preferably in combination with at least one component selected from the extract(s), fraction(s), active compound(s) and phytochemical(s) or mixtures thereof derived from. The ingredients and the composition(s) can be used for the control, prevention and treatment of obesity, metabolic syndrome, diabetes and other metabolic disorders, and also to regulate energy expenditure, prevention of atherosclerotic plaques in coronary artery and abdominal aorta, increase insulin sensitivity, improve glucose tolerance, lower triglyceride levels and balance glucose levels in mammals.

The invention discloses 4-(arylamino)selenophenopyrimidine derivatives of formula (I), hydrates, solvates, isomers, or pharmaceutically acceptable salts thereof; process for their preparation and methods of treating or inhibiting or controlling a cell proliferative disorders, particularly cancer using said compounds. Pharmaceutical compositions comprising 4-(arylamino)selenophenopyrimidine derivatives of formula (I) are useful for the treatment, inhibition, or control of cancer. 

Substituted 4-(arylamino) selenophenopyrimidine compounds and methods of use thereof

Selenophene compounds of formula (I) are described herein. In the compounds of Formula (I), ring A is a 6-membered aromatic fused ring, optionally containing one, two or three nitrogen atoms; a 5-membered heteroaromatic fused ring; or a mono- or bicyclic saturated heterocyclic fused ring having at least one ring member selected from the group consisting of N, O, S, SO and SO; Y in ring B is nitrogen or substituted carbon; X is NR, O, S, S(O), or S(O). R, R, R, R, and Rare defined in the specification. Selenophene compounds of formula (I) may be used in methods of treating cell proliferative disorders, particularly cancer. Pharmaceutical compositions containing selenophene compounds of formula (I) may be used for treatment, inhibition, or control of cancer. 

Substituted 4-(selenophen-2(or-3)-ylamino)pyrimidine compounds and methods of use thereof

Analogs of 3-O-acetyl-11-keto-beta-boswellic acid and their method of preparation are presented. The analogs may be used as anti-inflammatory and anti-cancer agents. The compounds inhibit 5-lipoxygenase enzyme and various cell lines related to inflammation as well as to cancer showing a significantly better efficacy when compared to the normal boswellic acids. The analogs are capable of controlling and treating various inflammatory diseases and cancers.

Analogs of 3-O-acetyl-11-keto-beta-boswellic acid

The invention discloses herbal ingredient(s) derived fromcomprising herb powder(s), extract(s), fraction(s), pure compound(s) or mixtures thereof and their compositions for alleviating metabolic disorders selected from metabolic syndrome, obesity, diabetes, atherosclerosis, endothelial dysfunction and other metabolic disorders or conditions; the for amelioration of different biological marker proteins and metabolic processes associated metabolic disorders.

Herbal compositions having anti-adipocyte fatty acid-binding protein (aP2), anti-5-lipoxygenase-activating protein (FLAP) and anti-Cysteinyl Leukotriene (CysLT)-1 receptor expression activity contain an extract of. More particularly, these herbal compositions comprise an effective amount of an enrichedextract containing from 10% to 99% by weight of 3-0-acetyl-11-keto-&#x3b2;-boswellic acid; and an effective amount of a second extract selected from the group consisting of an extract of, an extract of, an extract of, and mixtures thereof. These may be used in dietary supplements or pharmaceutical formulations for controlling diseases associated with or related to inflammation. These diseases in particular include respiratory disorders such as asthma, allergic rhinitis, hay fever, type-1 hypersensitivity and mild allergies. The compositions can also be useful for skin care.

Growing community of inventors

Vijayawada, India

Krishanu Sengupta